Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Heartbeat Introduces New Agency Leadership

Heartbeat announced that its founder Bill Drummy has stepped down as CEO after 18 years of running the perennially successful healthcare marketing agency.

Read More »

Merrimack Stockholders Approve Sale of Onivyde and Generic Version of Doxil to Ipsen for Up to $1.025 Billion

Merrimack Pharmaceuticals Inc. announced that the company will sell to Ipsen SA its first commercial product Onivyde and
its generic version of doxorubicin hydrochloride (HCI) liposome injection, which is marketed in the United States as Doxil.

Read More »

U.S.-UK alliance targets the world’s deadliest superbugs

Eleven biotech companies and research teams in Britain and the United States were awarded up to $48 million in funding to speed development of new antibiotics powerful enough to take on the world’s deadliest superbugs.

Read More »

SSCG Media Group Study: The Rule of Three

  SSCG Media Group Study Finds “Rule of Three” is Most Effective in Reaching Physicians with Pharma Advertising     NEW YORK, March 30, 2017 /PRNewswire/ — How can pharma advertisers best engage physicians? A leading pharma-focused media company went straight to the source to find out that the answer is the “Rule of Three.”  Today, […]

Read More »

Corbus drug shows promise as add-on therapy for cystic fibrosis

An anti-inflammatory drug being developed by Corbus Pharmaceuticals Holdings as an add-on treatment for cystic fibrosis demonstrated promising safety and was well tolerated in a small midstage study, according to data released by the company.

Read More »

Mass Layoffs Hit Ariad Employees After Takeda’s $5.2 Billion Buyout Deal

Early in January 2017, Takeda Pharmaceutical acquired Cambridge, Mass.-based Ariad Pharmaceuticals for approximately $5.2 billion. The Boston Business Journal reported that less than half of Ariad’s 300 employees will remain at that company.

Read More »

Massachusetts’ Agenus to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring

Lexington, Mass.-based Agenus announced today that it will reorganize its business and operations, including cutting about 50 jobs.

Read More »

Novartis Wins Speedy Review of Leukemia Drug

In the race to get a CAR-T therapeutic to the market, Novartis announced that the U.S. FDA accepted its BLA filing and granted priority review for CTL019.

Read More »

GSK’s new CEO gets short-term win from generic Advair delay

GlaxoSmithKline’s new CEO Emma Walmsley won a short-term reprieve from the threat of generic Advair with a delay in U.S. approval for Mylan’s copy of the blockbuster lung inhaler.

Read More »

Essay Support

Essay Support A lot of students need essay support due to the fact university tasks are usually time consuming. Would you spend some time carrying out analysis for many random essay when you could utilize that extra time to do something diffrent fully?

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom